...
首页> 外文期刊>Investigative ophthalmology & visual science >The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes
【24h】

The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes

机译:糖尿病视网膜病变和糖尿病性黄斑水肿对1型和2型糖尿病健康相关生活质量的影响

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE. To assess the impact of diabetic retinopathy (DR) and diabetic macular edema (DME) on health-related quality of life (HRQoL) in type 1 and type 2 diabetes using the EuroQoL EQ-5D generic multi-attribute utility instrument (MAUI). METHODS. In this cross-sectional study, 577 patients with diabetes were recruited from specialized eye clinics in Melbourne, Australia. Each patient underwent clinical, biochemical, and anthropometric assessments. The severity of combined DR and DME (no DR/DME; mild NPDR [nonproliferative DR (NPDR)] and/or mild DME; moderate NPDR and/or moderate DME; and vision-threatening DR (VTDR) (severe NPDR or PDR and/or severe DME) in the worse eye was calculated. EQ-5D utility measures were the main outcome. Because the distribution of the utility measures was skewed, independent associations were explored using multivariate quantile regression models (five quintiles, namely 15th, 30th, 45th, 60th, 75th) ranging from poorest to highest HRQoL. RESULTS. Median age of the participants was 66 years (range, 26-90 years). Of the 577 participants, 223 (38.7%) had no DR/DME, 35 (6.1%) had mild NPDR/DME, 127 (22.0%) had moderate NPDR/DME, and 192 (33.3%) had VTDR. In adjusted models, neither presence nor severity of DR/DME was significantly associated with any quantile of the EQ-5D. In contrast, the presence of diabetic complications (other than DR) (β = -0.153; SE = 0.052; P < 0.001), other nonocular comorbidities (β = -0.115; SE = 0.038; P < 0.01), and higher body mass index (β = -0.007; SE = 0.002; P < 0.001) were all associated with worse HRQoL. CONCLUSIONS. Using a generic MAUI, the EQ-5D, the authors found that the presence or severity of DR/DME and concomitant vision loss were not associated with any quantile of HRQoL. These findings suggest that the EQ-5D lacks sensitivity in assessing the impact of the severity of DR/DME on HRQoL parameters and that condition-specific instruments may better capture the full impact of the association.
机译:目的。使用EuroQoL EQ-5D通用多属性实用工具(MAUI)评估糖尿病性视网膜病变(DR)和糖尿病性黄斑水肿(DME)对1型和2型糖尿病健康相关生活质量(HRQoL)的影响。方法。在这项横断面研究中,从澳大利亚墨尔本的专门眼科诊所招募了577名糖尿病患者。每位患者均接受了临床,生化和人体测量学评估。 DR和DME合并的严重程度(无DR / DME;轻度NPDR [非增殖性DR(NPDR)]和/或轻度DME;中度NPDR和/或中度DME;以及威胁视力的DR(VTDR)(严重NPDR或PDR和计算EQ-5D效用指标是主要结果,因为该效用指标的分布存在偏斜,因此使用多元分位数回归模型(五个五分位数,即15、30,结果:从最差到最高HRQoL,排在第45、60、75位。结果。参与者的中位年龄为66岁(范围:26-90岁)。在577位参与者中,有223位(38.7%)没有DR / DME,35位(轻度NPDR / DME为6.1%,中度NPDR / DME为127(22.0%),VTDR为192(33.3%);在校正模型中,DR / DME的存在和严重程度均与EQ的任何分位数均无显着相关-5D。相反,存在糖尿病并发症(DR除外)(β= -0.153; SE = 0.052; P <0.001),其他非眼合并症s(β= -0.115; SE = 0.038; P <0.01)和较高的体重指数(β= -0.007; SE = 0.002; P <0.001)均与较差的HRQoL相关。结论。作者使用通用MAUI EQ-5D发现DR / DME的存在或严重程度以及伴随的视力丧失与HRQoL的分位数无关。这些发现表明,EQ-5D在评估DR / DME的严重程度对HRQoL参数的影响时缺乏敏感性,而针对特定病情的仪器可能会更好地捕获关联的全部影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号